Literature DB >> 12724757

Calcium and heart failure: the cycle game.

Kenneth R Chien, John Ross, Masahiko Hoshijima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12724757     DOI： 10.1038/nm0503-508

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure.

Authors:  Elizabeth L Lockamy; Razvan L Cornea; Christine B Karim; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2011-04-12       Impact factor: 3.575

2.  ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.

Authors:  Martin Bienengraeber; Timothy M Olson; Vitaliy A Selivanov; Eva C Kathmann; Fearghas O'Cochlain; Fan Gao; Amy B Karger; Jeffrey D Ballew; Denice M Hodgson; Leonid V Zingman; Yuan-Ping Pang; Alexey E Alekseev; Andre Terzic
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

Review 3.  The Ca 2+ leak paradox and rogue ryanodine receptors: SR Ca 2+ efflux theory and practice.

Authors:  Eric A Sobie; Silvia Guatimosim; Leticia Gómez-Viquez; Long-Sheng Song; Hali Hartmann; M Saleet Jafri; W J Lederer
Journal:  Prog Biophys Mol Biol       Date:  2005-07-18       Impact factor: 3.667

4.  Accurate quantitation of phospholamban phosphorylation by immunoblot.

Authors:  Naa-Adjeley Ablorh; Tyler Miller; Florentin Nitu; Simon J Gruber; Christine Karim; David D Thomas
Journal:  Anal Biochem       Date:  2012-02-03       Impact factor: 3.365

5.  Dynamics-Driven Allostery Underlies Ca2+-Mediated Release of SERCA Inhibition by Phospholamban.

Authors:  Olga N Raguimova; Rodrigo Aguayo-Ortiz; Seth L Robia; L Michel Espinoza-Fonseca
Journal:  Biophys J       Date:  2020-09-24       Impact factor: 4.033

6.  Cantú syndrome is caused by mutations in ABCC9.

Authors:  Bregje W M van Bon; Christian Gilissen; Dorothy K Grange; Raoul C M Hennekam; Hülya Kayserili; Hartmut Engels; Heiko Reutter; John R Ostergaard; Eva Morava; Konstantinos Tsiakas; Bertrand Isidor; Martine Le Merrer; Metin Eser; Nienke Wieskamp; Petra de Vries; Marloes Steehouwer; Joris A Veltman; Stephen P Robertson; Han G Brunner; Bert B A de Vries; Alexander Hoischen
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

7.  Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice.

Authors:  Nicoletta Potenza; Carmine Vecchione; Antonella Notte; Assunta De Rienzo; Annamaria Rosica; Lisa Bauer; Andrea Affuso; Mario De Felice; Tommaso Russo; Roberta Poulet; Giuseppe Cifelli; Gabriella De Vita; Giuseppe Lembo; Roberto Di Lauro
Journal:  EMBO Rep       Date:  2005-05       Impact factor: 8.807

8.  Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines.

Authors:  Lawrence T Bish; Meg M Sleeper; Caryn Reynolds; Jeffrey Gazzara; Elanor Withnall; Gretchen E Singletary; George Buchlis; Daniel Hui; Katherine A High; Guangping Gao; James M Wilson; H Lee Sweeney
Journal:  Hum Gene Ther       Date:  2011-06-08       Impact factor: 5.695

9.  Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.

Authors:  Tong Zhang; Tao Guo; Shikha Mishra; Nancy D Dalton; Evangelia G Kranias; Kirk L Peterson; Donald M Bers; Joan Heller Brown
Journal:  Circ Res       Date:  2009-12-03       Impact factor: 17.367

10.  Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.

Authors:  Yonggang Liu; F Steven Korte; Farid Moussavi-Harami; Man Yu; Maria Razumova; Michael Regnier; Michael T Chin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.